4 results for Farmacovigil?ncia e relat¨®rios de seguran?a
Big news! ? Repost: .shawe For ¾ÅÉ«, revenue figures are important to us because they represent the sum total of the value we¡¯re able to add to our clients¡¯ businesses through the services and technology we provide. Exceeding the $/pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/1 billion mark in annual revenue in our 29th year is an achievement that we¡¯ve aimed for from the beginning¡ªand it took a village. - Our gratitude to our clients, our people, our translators, and our other vendors and partners cannot be overstated. We can never repay those who have stuck by us, overcome monumental adversity, and seen us through to this moment in history. But we can ¡°pay it forward,¡± so to speak, by continuing to bring the highest value and most innovative solutions to our customers¡ªand by always delivering with the most attentive and client-focused service levels. - Thank you to everyone internally and externally who played a role in making the dream of surpassing this milestone into a reality! . . .
November /pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/1 202/pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/1
World Travel Market starts today, and ¾ÅÉ« is exhibiting! Join our VP of Travel ¾ÅÉ« and team to learn how your company can bounce back in the travel and hospitality industry. - -
November /pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/1 202/pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/1
Q3 was one for the books! We¡¯re so grateful for our dedicated employees and loyal clients for helping us reach our biggest milestone yet. ? - "The $/pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/1 billion mark is a milestone we've had our sights on for a long time. While sales performance is not our only important metric, our philosophy is that beyond being a good indicator of overall demand, revenue helps measure how much value we're able to add to our clients' businesses in totality," said our CEO, .shawe. - -
October 28 202/pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/1
Repost:.shawe The ¾ÅÉ« Global Leadership Conference in 2008 marked our /pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/15th year in business, and was a special conference for many reasons¡ªbut particularly because of our Keynote Speaker. - Former Secretary of State, General Colin Powell, whose heartfelt words about leadership and trust¡ªand always being the kind of manager that other people want to bring their problems to¡ªcontinue to inspire me and many members of our team to this day. - I'm beyond saddened to hear of his passing and send my deepest condolences to his family and loved ones. - -
October /pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/19 202/pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/1
For ¾ÅÉ«, revenue figures are important to us because they represent the sum total of the value we¡¯re able to add to our clients¡¯ businesses through the services and technology we provide. Exceeding the $/pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/1 billion mark in annual revenue in our 29th year is an achievement that we¡¯ve aimed for from the beginning¡ªand it took a village. Our gratitude to our clients, our people, our translators, and our other vendors and partners cannot be overstated. We can never repay those who have stuck by us, overcome monumental adversity, and seen us through to this moment in history. But we can ¡°pay it forward,¡± so to speak, by continuing to bring the highest value and most innovative solutions to our customers¡ªand by always delivering with the most attentive and client-focused service levels. Thank you to everyone internally and externally who played a role in making the dream of surpassing this milestone into a reality!
November /pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/1 202/pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/1
World Travel Market starts today, and ¾ÅÉ« is exhibiting! Join our VP of Travel ¾ÅÉ« and team to learn how your company can bounce back in the travel and hospitality industry. Learn how we can help:
November /pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/1 202/pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/1
Many of our senior leaders are longtime ¾ÅÉ« veterans who have worked their way up through the company. But our new Vice President of Growth Strategies, Edgar Vargas Casta?eda, is an exception -- and we're so glad to have him. Learn about his expertise and what he brings to ¾ÅÉ« here:
November /pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/1 202/pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/1
Tickets for the are available now! Join us in Nashville on December 30 for a great game with great company:
October 29 202/pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/1
A 75% increase in revenue? Yes, please! Watch the video to learn how we helped achieve these numbers within the and industries, then click here to learn more:
@Transperfect
November /pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/13 2020
How do projects work for freelance at ¾ÅÉ«? Read all about the process here:
@Transperfect
November /pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/12 2020
RT : Yesterday was record-breaking! 2020 was a huge success. Check out these post-event strategies to keep shoppers¡
@Transperfect
November /pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/12 2020
Where there are challenges, there is opportunity -- and 2020 has brought plenty of both. Here are five reasons why now is the time for companies to evaluate their white space opportunities:
@Transperfect
November /pt/industries/life-sciences/pharmacovigilance-and-safety-reporting/12 2020
As principais organiza??es farmac¨ºuticas, de biotecnologia, CRO e de sa¨²de confiam na ¾ÅÉ«
±á¾±²õ³Ù¨®°ù¾±²¹s de clientes
O que nossos clientes t¨ºm a dizer
A ¾ÅÉ« permite que a Pfizer receba a aprova??o do CFDA para um novo medicamento contra o c?ncer de mama
Os servi?os de TMF e tradu??o da ¾ÅÉ« permitem que a Karyopharm acelere a aprova??o da FDA para pacientes com mieloma
O grupo de reda??o m¨¦dica da ¾ÅÉ« permite que a Shire forne?a suporte de informa??es m¨¦dicas de primeira classe
As tradu??es da ¾ÅÉ« permitiram que a iniciativa Angels da Boehringer Ingelheim aumentasse sua comunidade global de centros de AVC
Global CRO Clinipace seleciona as solu??es e-fasibility e eTMF da Trial Interactive para agilizar os estudos de seus patrocinadores
A ¾ÅÉ« d¨¢ suporte ao BMS para manter a consist¨ºncia nos programas de treinamento em seus principais idiomas